Physician profile
Lizbeth Brice
NPI 1548555113
$851.93
in general payments reported to CMS, 2019-2025
13 companies · $400 in 2025
The $400 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.02 · 2021: $15.98 · 2022: $81.53 · 2023: $79.79 · 2024: $258 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $178.58 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $171.36 | 2023-2025 | Eliquis, Camzyos |
| Abiomed | $132.75 | 2025 | |
| Pfizer INC. | $79.83 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $76.86 | 2024-2025 | |
| Amgen INC. | $62.16 | 2023-2024 | Repatha |
| Abbott Laboratories | $47.38 | 2021-2025 | Jot Dx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.89 | 2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $19.18 | 2023 | Brilinta |
| Kestra Medical Technology Services, INC. | $19.03 | 2025 | Assure Wcd |
| Boston Scientific Corporation | $17.02 | 2020 | |
| Sanofi-Aventis U.S. LLC | $14.93 | 2023 | |
| Merck Sharp & Dohme LLC | $12.96 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lizbeth Brice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.